Dipenkumar Modi is a Primary Care physician. OpenAlex indexes 158 publications with 1,404 citations (h-index 20); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant
Sponsor: Barbara Ann Karmanos Cancer Institute
- Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
Sponsor: Barbara Ann Karmanos Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RegeneronProgram year2025130 paymentsResearch$694,389openpaymentsdata.cms.gov ↗
- Bristol Myers SquibbProgram year20251 paymentResearch$228,084openpaymentsdata.cms.gov ↗
- GenentechProgram year202548 paymentsResearch$188,310openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fei Wang, MD
Cornell University
Michael Hassman, DO
Barbara Rizzardi, MD
Kimball Johnson, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”